Home/Filings/4/0001171843-15-000650
4//SEC Filing

Anika Therapeutics, Inc. 4

Accession 0001171843-15-000650

$ANIKCIK 0000898437operating

Filed

Feb 4, 7:00 PM ET

Accepted

Feb 5, 5:07 PM ET

Size

5.3 KB

Accession

0001171843-15-000650

Insider Transaction Report

Form 4
Period: 2015-02-03
LUPPINO FRANCESCO J
Chief Operating Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2015-02-03+3,100
    Exercise: $39.69Exp: 2025-02-03Common Stock (3,100 underlying)
Footnotes (1)
  • [F1]The stock options vest in four equal annual installments beginning February 3, 2016.

Issuer

Anika Therapeutics, Inc.

CIK 0000898437

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000898437

Filing Metadata

Form type
4
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 5:07 PM ET
Size
5.3 KB